Skip to main content
VIB.BE
en
  • English
  • Dutch
About
Home
  • Research & Impact
    • Research Areas
      • Immunity & Inflammation
      • Cancer Research
      • Medical Biotechnology
      • Neuroscience
      • Plant Biology
      • Microbiology
      • Structural Biology
      • Computational Biology
    • Research Centers
      • Center for Cancer Biology
      • VIB.AI: Center for AI & Computational Biology
      • Center for Inflammation Research
      • Center for Medical Biotechnology
      • Center for Microbiology
      • Center for Molecular Neurology
      • Center for Structural Biology
      • Center for Plant Systems Biology
      • VIB-KU Leuven Center for Neuroscience
    • Grand Challenges
      • Selected projects
      • Societal impact
      • Upcoming call
      • Modalities
      • Contact
    • Translational Research
    • Research Impact
      • IPBO
      • Biotech for security and public health resilience
      • Aureus Nova Scientia Prize
    • Publications
    • Responsible Research
      • Why animal research is necessary
    • Research Infrastructure
      • ESFRI
  • Business
    • Business Development
      • VIB’s Business Development team
      • Technology transfer
    • New Ventures
      • From idea to spin-off
      • Embarking on a long-term adventure
      • VIB's Spin-offs
    • Intellectual Property
    • Ecosystem
      • Biotope
    • Discovery Sciences
      • Internship program
    • AI Studio
    • Success Stories
      • Towards a COVID-19 Drug
      • Revolutionary diagnostic cancer test
      • On the road to new asthma therapeutics
      • Antibodies for piglets
      • Agribiotech cluster in Ghent
      • Blood test for liver diseases
      • Safe test for mother and child
      • Toward new cancer medicines
      • Experimental micro-brewery of VIB and KU Leuven
      • Nanobodies, our legacy
      • DNA sequencing tools with our technology
    • Facilities
  • Technologies
    • Tech Portfolio
      • Bioimaging
      • Flow cytometry
      • Metabolomics
      • Nanobody production
      • Nucleomics
      • Protein production
      • Proteomics
      • Research data services
      • Screening
      • Single cell technology
      • Technology scouting
      • Spatial Catalyst
    • About VIB technologies
      • Our dual mission
      • Meet our experts
      • Technology Training
      • Jobs
      • Core for Life
      • Partner with VIB Technologies
  • Public Outreach
    • Facts Series
    • Educational Projects
    • Events
  • News
    • Press
    • Called to Science
    • VIBTimes
    • Blog
    • In the spotlight
      • VIB Microbes
      • VIB Lessons from Plants
      • VIB Technologies
      • Neuroscience
  • Training & Conferences
    • Partner events
  • Careers
    • Jobs
    • Why VIB?
    • DE&I
    • Supporting your journey
    • Grants Office
    • Why Flanders?
  • Research & Impact
    • Research Areas
      • Immunity & Inflammation
      • Cancer Research
      • Medical Biotechnology
      • Neuroscience
      • Plant Biology
      • Microbiology
      • Structural Biology
      • Computational Biology
    • Research Centers
      • Center for Cancer Biology
      • VIB.AI: Center for AI & Computational Biology
      • Center for Inflammation Research
      • Center for Medical Biotechnology
      • Center for Microbiology
      • Center for Molecular Neurology
      • Center for Structural Biology
      • Center for Plant Systems Biology
      • VIB-KU Leuven Center for Neuroscience
    • Grand Challenges
      • Selected projects
      • Societal impact
      • Upcoming call
      • Modalities
      • Contact
    • Translational Research
    • Research Impact
      • IPBO
      • Biotech for security and public health resilience
      • Aureus Nova Scientia Prize
    • Publications
    • Responsible Research
      • Why animal research is necessary
    • Research Infrastructure
      • ESFRI
  • Business
    • Business Development
      • VIB’s Business Development team
      • Technology transfer
    • New Ventures
      • From idea to spin-off
      • Embarking on a long-term adventure
      • VIB's Spin-offs
    • Intellectual Property
    • Ecosystem
      • Biotope
    • Discovery Sciences
      • Internship program
    • AI Studio
    • Success Stories
      • Towards a COVID-19 Drug
      • Revolutionary diagnostic cancer test
      • On the road to new asthma therapeutics
      • Antibodies for piglets
      • Agribiotech cluster in Ghent
      • Blood test for liver diseases
      • Safe test for mother and child
      • Toward new cancer medicines
      • Experimental micro-brewery of VIB and KU Leuven
      • Nanobodies, our legacy
      • DNA sequencing tools with our technology
    • Facilities
  • Technologies
    • Tech Portfolio
      • Bioimaging
      • Flow cytometry
      • Metabolomics
      • Nanobody production
      • Nucleomics
      • Protein production
      • Proteomics
      • Research data services
      • Screening
      • Single cell technology
      • Technology scouting
      • Spatial Catalyst
    • About VIB technologies
      • Our dual mission
      • Meet our experts
      • Technology Training
      • Jobs
      • Core for Life
      • Partner with VIB Technologies
  • Public Outreach
    • Facts Series
    • Educational Projects
    • Events
  • News
    • Press
    • Called to Science
    • VIBTimes
    • Blog
    • In the spotlight
      • VIB Microbes
      • VIB Lessons from Plants
      • VIB Technologies
      • Neuroscience
  • Training & Conferences
    • Partner events
  • Careers
    • Jobs
    • Why VIB?
    • DE&I
    • Supporting your journey
    • Grants Office
    • Why Flanders?
  • Log in
en
  • English
  • Dutch
About

Facilities

To translate science into benefits for society, technology transfer is essential. Bio-incubators and accelerators are a crucial component of a life sciences ecosystem that enables technology transfer.

Through providing specialized infrastructure to young and established companies, incubators and accelerators act as a breeding ground for innovation. Both young start-ups and international pharmaceutical companies can develop, find important partners, and tap into available talent and know-how.

VIB pioneered the exploitation of the first bio-incubator in the late 1990s in Ghent. Since then, we've grown our incubators to more than 25,000 m² of specialized infrastructure. All of our incubators are fully licensed to conduct biotech activities and are available for local and international partners in the life sciences sector.
Facilities

Questions

Questions for the Flemish Gut Project
Questions

Practical

Practical information for the Flemish Gut Project
Practical

The Flemish Gut Flora Project

In this ambitious project, we are trying to find out more about the role of gut bacteria in health with the help of thousands of Flemish volunteers. We collect and examine stool samples from more than 5000 participants. This has never happened on this scale worldwide. Here you will find all information and news about the research project.
The Flemish Gut Flora Project

Technology News

Discover VIB Technologies News and stay up to date!
Technology News

Pagination

  • First page ‹‹
  • Previous page ‹
  • …
  • Page 14
  • Page 15
  • Current page 16
  • Page 17
  • Page 18
  • …
  • Next page ›
  • Last page ››

Footer

Keep me informed about VIB news and events
Home
  • Contact
  • Donate
  • Sitemap

VIB

Suzanne Tassierstraat 1
9052 Ghent
Belgium

BE 0456 343 923

+32 9 244 66 11info@vib.be

Follow us

facebook
instagram
bluesky
youtube
linkedin
vimeo
  • © VIB
  • Cookie policy
  • Disclaimer
  • Privacy
Administrator login Cookie preferences